CheckCap (CHEK)
(Delayed Data from NSDQ)
$1.73 USD
0.00 (0.00%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $1.73 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.73 USD
0.00 (0.00%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $1.73 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.
3 Reasons to Retain Baxter (BAX) Stock in Your Portfolio
by Zacks Equity Research
Investors remain optimistic about Baxter (BAX) due to its strong product portfolio.
CheckCap Ltd. (CHEK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
CheckCap Ltd. (CHEK) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
The Zacks Analyst Blog Highlights ShockWave Medical, CheckCap and Biosig Technologies
by Zacks Equity Research
ShockWave Medical, CheckCap and Biosig Technologies are part of The Zacks top Analyst Blog.
3 Medical Instruments Stocks With Potential to Outperform
by Zacks Equity Research
Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.
CheckCap Ltd. (CHEK) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
CheckCap Ltd. (CHEK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CheckCap Ltd. (CHEK) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
CheckCap Ltd. (CHEK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About CheckCap Ltd. (CHEK) Rating Upgrade to Buy
by Zacks Equity Research
CheckCap Ltd. (CHEK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Check-Cap Ltd. (CHEK) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Check-Cap Ltd. (CHEK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Check-Cap Ltd. (CHEK) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Check-Cap Ltd. (CHEK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Luminex (LMNX) Looks Good: Stock Adds 5.7% in Session
by Zacks Equity Research
Luminex (LMNX) shares rose nearly 6% in the last trading session, amid huge volumes.
4 Stocks to Buy at Their 52-Week Lows
by Ryan McQueeney
While many momentum-focused investors focus on buying stocks near new highs and hoping the upward trend continues, other investors find value in searching for stocks that are poised to rebound after hitting new lows. Check out these slumping stocks that could be poised for a rebound soon.
The Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health Solutions
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PRA Health Sciences, Mesa Laboratories, ConforMIS, Check-Cap and Streamline Health Solutions
5 MedTech Stocks to Buy Before Q3 Earnings
by Zacks Equity Research
The Q3 earnings season is just around the corner for the political hotspot MedTech space.